1
Disease Intelligence
Understand the disease and its market.
- Patient populations and epidemiology
- Clinical trial landscape
- Pricing and market intelligence
- Commercial payoff inputs
- Evidence grades and provenance
Clinical-trial and disease intelligence
ClinoviaClinical Intelligence. Better Decisions.
Clinical-trial and disease intelligence to help biotech sponsors and CROs evaluate opportunities, understand feasibility, and make better-informed clinical development decisions.
How the platform connects
Available now- 22,401
- Neurodegenerative disease estimates
Platform
Explore the Platform
Two products, available for neurodegenerative diseases and Type 1 diabetes.
2
Study Intelligence
Evaluate and plan a clinical study.
- Country, site and investigator feasibility
- Indication-specific study budgeting
- Cost of each month of delay
- Scenario comparison
Services
Intelligence Reports & Pilot Programs
Study-specific analysis for biotech sponsors and CROs, delivered as a written report and reviewed with your team.
01
Protocol and Eligibility Assessment
How inclusion and exclusion criteria shape the eligible population, and where the protocol adds recruitment risk.
- Criterion-by-criterion population funnel
- Benchmark against comparable registered trials
- Risk register with recommendations
Know which criteria cost you the most patients.
View sample report02
Site and Patient Feasibility
Where eligible patients and experienced sites are located, and how competing studies affect recruitment.
- Patient distribution by state and region
- Site and investigator shortlist by trial experience
- Enrollment scenarios with stated assumptions
Choose sites with evidence, not habit.
View sample report03
Study Budgeting
A structured cost estimate by cost type, with scenarios and the cost of each month of delay.
- Per-site, per-patient, fixed and monthly costs
- Low, base and high scenarios
- Line-by-line review of CRO or site proposals
A budget you can explain line by line.
View sample report04
Commercial Opportunity Assessment
Patient, treatment and pricing inputs brought together into transparent opportunity scenarios.
- Eligible and treated population
- Dose and price inputs from public sources
- Scenario ranges with sensitivity
See which assumptions move the opportunity.
View sample reportPilot programs
Start with one report on one study, review it together, then decide on a broader engagement.
Custom software
Custom Software Development
Tailored clinical research and healthcare AI solutions.
Discuss a Custom SolutionClinical data platforms
Analytics dashboards
Predictive modeling
Data integration and automation
How it works
From public data to decisions you can defend
Four steps, each one visible, so you always know where a number came from and how it was built.
Step 1
Collect
Public, authoritative sources: Census population, ClinicalTrials.gov, CMS drug pricing and published epidemiology.
Step 2
Validate and grade
Every value is checked, kept with its source and graded A Confirmed to D Assumed.
Step 3
Model
Population, trial, site, budget and commercial views built with calculations you can inspect.
Step 4
Decide
Dashboards and reports that support, not replace, your clinical development decisions.
About
About Clinovia
Clinovia brings clinical-trial and disease information together as structured, sourced intelligence. Its outputs support the people who plan clinical development; they do not replace clinical, regulatory or investment judgement.
Request a Demo
See how Clinovia supports clinical development decisions.
A guided session with the Clinovia team, focused on the indication and the decisions in front of you.
Your walkthrough
3 partsPart 1
Personalized walkthrough.
Built around your indication and your questions.
Part 2
Explore relevant indications.
See the disease, trial and site views for your area.
Part 3
Discuss business requirements.
Reports, pilots or custom software: what you need next.